Oligosaccharide analytical standards

US11780872B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11780872-B2
Application numberUS-202017116706-A
CountryUS
Kind codeB2
Filing dateDec 9, 2020
Priority dateDec 9, 2019
Publication dateOct 10, 2023
Grant dateOct 10, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are oligosaccharides and intermediates useful for the production thereof. The compounds are useful as analytical standards and as intermediates for the preparation of more complex oligosaccharide and N-glycan products. The compounds may be prepared in high purity using the selective stop/go synthetic methods disclosed herein.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound having the formula: or a salt thereof, wherein R MG2 is H or has the structure: wherein R 5 is N 3 or NR 5a R 5b , wherein R 5a and R 5b are the same or different, and are H or Z—X 5 wherein Z is null, C═O, or SO 2 , and X 5 is C 1-4 alkyl, O—C 1-4 alkyl, C 1-4 haloalkyl, 0-C 1-4 haloalkyl, C 1-4 alkylaryl, O—C 1-4 alkylaryl, aryl, or O-aryl; or R 5a and R 5b can together form a ring; or R 5 is a radical having the formula: wherein one or both of R 5c or R 5d constitute a conjugated payload; R MG3 is H or has the structure: wherein R 11 is N 3 , or NR 11a R 11b , wherein R 11a and R 11b are the same or different, and are H or Z—X 11 wherein Z is null, C═O, or SO 2 , and X 11 is C 1-4 alkyl, O—C 1-4 alkyl, C 1-4 haloalkyl, O—C 1-4 haloalkyl, C 1-4 alkylaryl, O—C 1-4 alkylaryl, aryl, O-aryl; or R 11a and R 11b can together form a ring; or R 11 can be a radical having the formula: wherein one or both of R 11c or R 11d constitute a conjugated payload; R MG4 is H or has the structure: wherein R 9 is N 3 , or NR 9a R 9b , wherein R 9a and R 9b are the same or different, and are H or Z—X 9 wherein Z is null, C═O, or SO 2 , and X 9 is C 1-4 alkyl, O—C 1-4 alkyl, C 1-4 haloalkyl, O—C 1-4 haloalkyl, C 1-4 alkylaryl, O—C 1-4 alkylaryl, aryl, O-aryl; or R 9a and R 9b can together form a ring; or R 9 can be a radical having the formula: wherein one or both of R 9c or R 9d constitute a conjugated payload; R MG5 is H or has the structure: wherein R 10 is N 3 or NR 10a R 10b , wherein R 10a and R 10b are the same or different, and are H or Z—X 10 wherein Z is null, C═O, or SO 2 , and X 10 is C 1-4 alkyl, O—C 1-4 alkyl, C 1-4 haloalkyl, O—C 1-4 haloalkyl, C 1-4 alkylaryl, O—C 1-4 alkylaryl, aryl, or O-aryl; or R 10a and R 10b can together form a ring; or R 10 can be a radical having the formula: wherein one or both of R 10c or R 10d constitute a conjugated payload; R 12 is hydrogen or a residue having the formula: wherein R 13 is hydrogen or a residue having the formula: wherein R 13b is selected from H and a conjugated cargo moiety, and R 13a is selected from OH and a conjugated cargo moiety; R 14 is hydrogen or a residue having the formula: wherein R 14b is selected from H and a conjugated cargo moiety, and R 14a is selected from OH and a conjugated cargo moiety; R 1 is OH, or a residue having the formula: R oz is H, C 1-4 alkyl, aryl, CF 3 , or CCl 3 , n is 1 or 0; R fa is H or a fucose residue having the structure: R 2 is OR c , NR 2n OR c , or NR 2n R c ; and R 3 is OR c or R c ; wherein: R 2n is H or C 1-4 alkyl; R c is X p H, X p C 1-8 alkyl, X p C 1-8 alkylaryl, X p aryl, X p fluorescent marker, or an amino acid residue having the formula: wherein R aa1 and R aa2 are selected from H, protecting group and additional amino acid residues; R 3 is X p C 1-8 alkyl, X p C 1-8 alkylaryl, or X p aryl; wherein X p is null or (CH 2 CH 2 O) z , wherein z is 1-500; R 4 is N 3 , or NR 4a R 4b , wherein: R 4a and R 4b are the same or different, and are H or Z—X 4 wherein Z is null, C═O, or SO 2 , and X 4 is C 1-4 alkyl, O—C 1-4 alkyl, C 1-4 haloalkyl, O—C 1-4 haloalkyl, C 1-4 alkylaryl, O—C 1-4 alkylaryl, aryl, or O-aryl; or R 4a and R 4b can together form a ring; or R 4 is a radical having the formula: wherein one or both of R 4c or R 4d constitute a conjugated payload. 2. The compound according to claim 1 , wherein R 1 is a residue having the formula: R c is an amino acid residue having the formula: and R aa1 and R aa2 are independently selected from H and Z a —X a wherein Z a is null, C═O, SO 2 , and X a can be C 1-4 alkyl, O—C 1-4 alkyl, C 1-4 haloalkyl, O—C 1-4 haloalkyl, C 1-4 alkylaryl, O—C 1-4 alkylaryl, aryl, or O-aryl. 3. The compound according to claim 2 , wherein R aa1 is Cbz (carboxybenzyl ether), and R aa2 is H. 4. The compound according to claim 1 , wherein R 1 has formula: 5. The compound according to claim 1 , wherein R 1 is a residue having the formula: 6. The compound according to claim 5 , wherein R 1 is a residue having the formula:  wherein R c has the formula —(CH 2 ) nc R im , wherein nc is an integer from 1-8, and R im is —NH 2 , —SH, —OH, —COOH, —N 3 , C≡CH, a Michael acceptor, SO 3 , OSO 3 , or a biotin residue having the formula: wherein X bt is selected from null, O, NH, or S. 7. The compound according to claim 5 , wherein R c is selected from coumarins, rhodamines, fluoresceins, cyanines, eosins, and erythrosins. 8. The compound according to claim 5 , wherein R c is a C 1-8 alkylaryl or aryl. 9. The compound according to claim 5 , wherein R c is a group having the formula: wherein np is from 0-50, ns is from 2-7, and ns′ is from 2-5. 10. The compound according to claim 1 , wherein R MG2 , R MG3 , R MG4 and R MG5 are each hydrogen. 11. The compound according to claim 1 , having the formula:

Assignees

Inventors

Classifications

  • C07H5/06Primary

    Aminosugars · CPC title

  • Preparation of nitrogen-containing carbohydrates · CPC title

  • Pyrimidine nucleotides · CPC title

  • Preparation of compounds containing saccharide radicals (ketoaldonic acids C12P7/58) · CPC title

  • produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11780872B2 cover?
Disclosed herein are oligosaccharides and intermediates useful for the production thereof. The compounds are useful as analytical standards and as intermediates for the preparation of more complex oligosaccharide and N-glycan products. The compounds may be prepared in high purity using the selective stop/go synthetic methods disclosed herein.
Who is the assignee on this patent?
Univ Georgia
What technology area does this patent fall under?
Primary CPC classification C07H5/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).